Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Idelalisib (GS-1101)-Associated Colitis - Molecular and Cellular Mechanisms Research Proposal

NCT02928510 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT02928510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02928510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Idelalisib (GS-1101)-Associated Colitis - Molecular and Cellular Mechanisms Research Proposal
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Observational
Overall status
Terminated
Start date
February 1, 2016
Completion date
June 5, 2018
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

absence of signs or symptoms, b-cell non-hodgkin lymphoma, digestive system signs and symptoms, indolent adult non-hodgkin lymphoma, recurrent b-cell non-hodgkin lymphoma, recurrent chronic lymphocytic leukemia, recurrent indolent adult non-hodgkin lymphoma, recurrent small lymphocytic lymphoma